You are using an older browser version. Please use a supported version for the best MSN experience.

Atai Life Sciences founder on using psychedelics to treat mental illness

Atai Life Sciences, a biotech company that uses psychedelics to treat mental illness, is going public on the Nasdaq Friday. Christian Angermayer, Atai Life Sciences founder, joined "Squawk Box" on Friday to discuss the company's mission and public debut.

UP NEXT

UP NEXT

CNBC

Fortune

image beaconimage beaconimage beacon